Medical imaging and radiology
Cleerly
AI-enabled CCTA analysis platform for coronary plaque assessment and heart attack prevention workflows.
Last updated: June 7, 2026
Back to directoryBayer Calantic Digital Solutions medical AI product profile
Bayer radiology AI platform that provides access to curated imaging AI applications through a cloud-hosted marketplace and PACS-integrated viewer.
Medical imaging and radiology
Best fit
Radiology teams that want a governed platform layer for deploying multiple third-party or Bayer imaging AI applications across service lines.
- Primary use case
- Cloud-hosted radiology AI platform for curated imaging applications, PACS-integrated viewing, triage, detection, quantification, and workflow orchestration
- Audience
- Radiology departments, hospitals, imaging networks, and radiology AI governance teams deploying multiple imaging algorithms
- Risk level
- High
- Pricing signal
- Subscription and usage terms vary by region, selected applications, and master license; verify current Bayer Calantic commercial terms.
- Official sources
- 4 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Bayer Calantic Digital Solutions as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat Calantic as a platform plus selected application stack; verify each deployed app's device status, intended use, indication, version, jurisdiction, and responsibility split between Bayer and the app vendor. |
|---|---|
| Privacy | Review image routing, DICOM metadata, cloud hosting, viewer access, app-vendor data flows, support access, retention, security controls, BAA or DPA terms, and whether PHI crosses vendors or regions. |
| Evidence | Validate each selected app locally by service line, scanner mix, prevalence, patient population, false-positive and false-negative profile, alert behavior, radiologist acceptance, and operational impact. |
| Workflow | Best governed as radiology AI infrastructure with an application intake board, per-app validation checklist, PACS/RIS integration testing, monitoring plan, and retirement process for underperforming algorithms. |
Where Bayer Calantic Digital Solutions fits
Bayer describes Calantic as a cloud-hosted radiology AI platform that gives radiologists access to a curated portfolio of applications for worklist prioritization, detection, quantification, and disease-area service lines through a PACS-integrated viewer. Bayer launch materials position it as a vendor-neutral platform for AI-enabled medical imaging applications, while subscription materials should be reviewed for security, licensing, medical-advice disclaimers, and customer data-processing obligations.
Not for: Treating marketplace availability as proof that every selected app is cleared, validated, or appropriate for the exact local modality, indication, and patient population.
What to verify before using Bayer Calantic Digital Solutions
- Which Calantic applications are available in the intended country, service line, modality, body region, and regulatory pathway.
- How the Calantic Viewer integrates with PACS/RIS/EHR workflows, worklist prioritization, result display, alerts, DICOM routing, and user audit trails.
- Per-application FDA, CE, or local authorization, intended use, version, vendor responsibility, support path, and clinical validation evidence.
- Cloud hosting, image and metadata processing, data retention, cross-border transfer, security program, BAA or DPA terms, and incident-response responsibilities.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.calantic.com
- www.calantic.com / en-us / about-us
- www.bayer.com / media / en-us
- www.radiologysolutions.bayer.com / files / Radimetrics-OC-Terms-and-Conditions.pdf
Related medical AI products
Medical imaging and radiology
Elucid PlaqueIQ
FDA-cleared non-invasive plaque analysis software for coronary CTA workflows that reports plaque composition and vessel-level findings.
Medical imaging and radiology
LumineticsCore
FDA De Novo-cleared autonomous diagnostic AI for detecting more-than-mild diabetic retinopathy in eligible adults with diabetes.
Medical imaging and radiology
Eyenuk EyeArt
FDA-cleared autonomous diabetic retinopathy screening system that analyzes retinal images and returns patient-level and eye-level screening results.